SCHEMBL2568110

SCHEMBL2568110

CN1CCc2ccc(NC(=O)[C@@](C)(COC(=O)N(C)C)NC(=O)Oc3ccc(Cl)s3)cc2CC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
AR P10275 5/20 0.33
RAB9A P51151 4/20 0.33
F10 P00742 3/20 0.33
NPC1 O15118 2/20 0.33
MAPK1 P28482 1/20 0.33
DRD2 P14416 2/20 0.32
HTR2C P28335 2/20 0.32
DRD3 P35462 2/20 0.32
HTR6 P50406 2/20 0.32
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32
APH1A Q96BI3 1/20 0.32
PSENEN Q9NZ42 1/20 0.32
ALDH1A1 P00352 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2571305 0.89 KDM4E (0.36) HDAC1HDAC2ARRAB9AF10
SCHEMBL3033869 0.88 F10 (0.44) ARRAB9AF10NPC1MAPK1
SCHEMBL2568969 0.87 RAB9A (0.36) HDAC1HDAC2ARRAB9AF10
SCHEMBL2567154 0.87 AR (0.33) HDAC1HDAC2ARRAB9AF10
SCHEMBL2571863 0.84 RAB9A (0.34) HDAC1HDAC2ARRAB9AF10
SCHEMBL2571214 0.84 KDM4E (0.40) HDAC1HDAC2ARRAB9AF10
SCHEMBL2566978 0.84 HRH3 (0.37) ARRAB9ANPC1MAPK1PSEN1
SCHEMBL2570993 0.83 NPC1 (0.33) HDAC1HDAC2ARRAB9AF10
SCHEMBL2572738 0.83 ALOX5 (0.35) HDAC1HDAC2ARRAB9AF10
SCHEMBL2568026 0.83 PSEN1 (0.33) HDAC1HDAC2ARRAB9AF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899330-B9 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2011-11-09 EP disclosed
EP-1899330-B1 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2010-11-24 EP disclosed